skip to content

Market News

PureTech Health launches Alivio Therapeutics

10 May 2016 07:47

PureTech Health has launched Alivio Therapeutics, which is developing a novel technology for the targeted treatment of inflammatory disorders.

"The technology is based on an innovative hydrogel material that is designed to adhere to and deliver drugs to inflamed tissue based on the degree of inflammation (e.g., more drug is released at site with greater inflammation)," said PureTech in a statement.

"This approach may help overcome major technical challenges in the field, enabling new therapies that have the potential to address multiple acute and chronic inflammatory disorders."

Story provided by

Related Company: PRTC

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

Bluezest Aberdeen

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.